Common Stock, Value, Issued of enGene Holdings Inc. from 31 Oct 2022 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: enGene Holdings Inc. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Oct 2022 to 31 Oct 2025.
enGene Holdings Inc. Common Stock, Value, Issued for the quarter ending 31 Oct 2025 was $513,281,000, a 0.68% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

enGene Holdings Inc. Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$513,281,000	+$3,470,000	+0.68%	31 Oct 2025	10-K	22 Dec 2025	2025	FY
Q2 2025	$510,164,000	+$56,685,000	+12%	31 Jul 2025	10-Q	11 Sep 2025	2025	Q3
Q1 2025	$510,121,000	+$56,716,000	+13%	30 Apr 2025	10-Q	12 Jun 2025	2025	Q2
Q4 2024	$509,812,000	+$250,439,000	+97%	31 Jan 2025	10-Q	10 Mar 2025	2025	Q1
Q3 2024	$509,811,000	+$250,438,000	+97%	31 Oct 2024	10-K	22 Dec 2025	2025	FY
Q2 2024	$453,479,000			31 Jul 2024	10-Q	10 Sep 2024	2024	Q3
Q1 2024	$453,405,000			30 Apr 2024	10-Q	14 Jun 2024	2024	Q2
Q4 2023	$259,373,000			31 Jan 2024	10-Q	11 Mar 2024	2024	Q1
Q3 2023	$259,373,000	+$242,983,000	+1483%	31 Oct 2023	10-K	19 Dec 2024	2024	FY
Q3 2022	$16,390,000			31 Oct 2022	10-K	29 Jan 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.